Time to abandon Brussels' bid on patents.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 7969499.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
After six years of debate, the European Commission's attempts to harmonize biotechnology legislation still face opposition over the patenting of genes. Recent legal experience suggests that its efforts are unnecessary.
Medical subject headings
- Genes
- Patents as Topic